PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications

PIMS (paediatric inflammatory multisystem syndrome associated with COVID-19 or Multisystem Inflammatory Syndrome in Children (MIS-C)) is a new disease classification, occurring in children and young adults associated with the SARS-CoV-2 infection. Although children suffer from COVID-19 infection as...

Full description

Bibliographic Details
Main Authors: Aleksandra Grudzińska, Paulina Dudzińska, Małgorzata Milanowska, Dominika Jarosz, Hanna Tsitko
Format: Article
Language:English
Published: Kazimierz Wielki University 2023-03-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/42695
_version_ 1827996186797146112
author Aleksandra Grudzińska
Paulina Dudzińska
Małgorzata Milanowska
Dominika Jarosz
Hanna Tsitko
author_facet Aleksandra Grudzińska
Paulina Dudzińska
Małgorzata Milanowska
Dominika Jarosz
Hanna Tsitko
author_sort Aleksandra Grudzińska
collection DOAJ
description PIMS (paediatric inflammatory multisystem syndrome associated with COVID-19 or Multisystem Inflammatory Syndrome in Children (MIS-C)) is a new disease classification, occurring in children and young adults associated with the SARS-CoV-2 infection. Although children suffer from COVID-19 infection asymptomatically or mildly, long-term complications of the disease may be more severe for them than for adults. Despite the fact that PIMS is a relatively new disease, we already know that it should not be underestimated. In spite of the clinical picture of these complications may resemble Kawasaki Disease (KD), we may notice some differences in laboratory tests (such as reduced number of lymphocytes, decreased platelet count or elevated ferritin levels). Although usually the first symptom of PIMS is high fever, it is followed by symptoms related to the digestive system, present in about 80% of cases. The insidious and severe gastrointestinal symptoms of PIMS can mimic abdominal surgical emergencies, including acute appendicitis, gastrointestinal infections or inflammatory bowel disease. Cardiovascular symptoms occur in approximately 60% of patients with PIMS. Immunomodulatory therapy plays an essential role in the treatment of PIMS. The exact causes of PIMS are recently unknown, however, it is explained as genetic hyperactivation of immunity. In this minireview we summarize the most recent data about this condition, mainly we are focusing on gastrointestinal and cardiovascular  symptoms, short/long-term complications and treatment.
first_indexed 2024-04-10T05:08:20Z
format Article
id doaj.art-80ca084348064ffcb4cf66d71bf88741
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-04-10T05:08:20Z
publishDate 2023-03-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-80ca084348064ffcb4cf66d71bf887412023-03-09T11:43:56ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062023-03-0113510.12775/JEHS.2023.13.05.004PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complicationsAleksandra Grudzińska0Paulina Dudzińska1Małgorzata Milanowska2Dominika Jarosz3Hanna Tsitko4Medical University of LublinMedical University of LublinMedical University of LublinMedical University of LublinMedical University of Lublin PIMS (paediatric inflammatory multisystem syndrome associated with COVID-19 or Multisystem Inflammatory Syndrome in Children (MIS-C)) is a new disease classification, occurring in children and young adults associated with the SARS-CoV-2 infection. Although children suffer from COVID-19 infection asymptomatically or mildly, long-term complications of the disease may be more severe for them than for adults. Despite the fact that PIMS is a relatively new disease, we already know that it should not be underestimated. In spite of the clinical picture of these complications may resemble Kawasaki Disease (KD), we may notice some differences in laboratory tests (such as reduced number of lymphocytes, decreased platelet count or elevated ferritin levels). Although usually the first symptom of PIMS is high fever, it is followed by symptoms related to the digestive system, present in about 80% of cases. The insidious and severe gastrointestinal symptoms of PIMS can mimic abdominal surgical emergencies, including acute appendicitis, gastrointestinal infections or inflammatory bowel disease. Cardiovascular symptoms occur in approximately 60% of patients with PIMS. Immunomodulatory therapy plays an essential role in the treatment of PIMS. The exact causes of PIMS are recently unknown, however, it is explained as genetic hyperactivation of immunity. In this minireview we summarize the most recent data about this condition, mainly we are focusing on gastrointestinal and cardiovascular  symptoms, short/long-term complications and treatment. https://apcz.umk.pl/JEHS/article/view/42695PIMSCovid-19MIS-CPediatricGastrointestinalCardiovascular
spellingShingle Aleksandra Grudzińska
Paulina Dudzińska
Małgorzata Milanowska
Dominika Jarosz
Hanna Tsitko
PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
Journal of Education, Health and Sport
PIMS
Covid-19
MIS-C
Pediatric
Gastrointestinal
Cardiovascular
title PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
title_full PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
title_fullStr PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
title_full_unstemmed PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
title_short PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
title_sort pims symptoms and short long term gastrointestinal and cardiovascular system complications
topic PIMS
Covid-19
MIS-C
Pediatric
Gastrointestinal
Cardiovascular
url https://apcz.umk.pl/JEHS/article/view/42695
work_keys_str_mv AT aleksandragrudzinska pimssymptomsandshortlongtermgastrointestinalandcardiovascularsystemcomplications
AT paulinadudzinska pimssymptomsandshortlongtermgastrointestinalandcardiovascularsystemcomplications
AT małgorzatamilanowska pimssymptomsandshortlongtermgastrointestinalandcardiovascularsystemcomplications
AT dominikajarosz pimssymptomsandshortlongtermgastrointestinalandcardiovascularsystemcomplications
AT hannatsitko pimssymptomsandshortlongtermgastrointestinalandcardiovascularsystemcomplications